Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.

Source:http://linkedlifedata.com/resource/pubmed/id/20471443

Vaccine 2010 Jul 12 28 31 5114-27

Download in:

View as

Triples

General Info

PMID
20471443